Effect of dabrafenib on melanoma cell lines harbouring the BRAF(V600D/R) mutations

BACKGROUND: Conventional therapeutic agents are largely unsatisfactory into the treatment of malignant melanoma. Recently, an innovative approach based on inhibitors of the mutated BRAF gene (which represents the most prevalent alteration in melanoma patients) appears very promising from the clinica...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Gentilcore, Giusy, Madonna, Gabriele, Mozzillo, Nicola, Ribas, Antoni, Cossu, Antonio, Palmieri, Giuseppe, Ascierto, Paolo A
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2013
Konular:
Correspondence
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3586362/
https://ncbi.nlm.nih.gov/pubmed/23317446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-17
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller